Starpharma Holdings Ltd
SPL
Company Profile
Business description
Starpharma Holdings Ltd is an Australian biotechnology company focused on developing targeted oncology therapeutics, including radiopharmaceuticals, using its clinically validated DEP (Dendrimer Enhanced Product) drug delivery platform. Leveraging more than 20 years of dendrimer expertise, it is advancing novel, proprietary assets and strategic partnerships aimed at improving patient outcomes.
Contact
4-6 Southampton Crescent
Abbotsford
MelbourneVIC3067
AUST: +61 385322700
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
Employees
32
Starpharma Holdings Ltd News & Analysis
stocks
CSL remains favourite, but biotech field broadening
The biotech giant has jumped 22pc a year for the past decade but new players are emerging.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,951.00 | 31.90 | 0.36% |
| CAC 40 | 8,157.65 | 18.71 | 0.23% |
| DAX 40 | 25,600.01 | 25.00 | 0.10% |
| Dow JONES (US) | 51,735.76 | 313.07 | -0.60% |
| FTSE 100 | 10,723.24 | 15.77 | -0.15% |
| HKSE | 25,087.75 | 45.04 | 0.18% |
| NASDAQ | 27,210.56 | 88.47 | 0.33% |
| Nikkei 225 | 65,018.95 | 882.70 | 1.38% |
| NZX 50 Index | 13,875.48 | 54.28 | 0.39% |
| S&P 500 | 7,760.15 | 4.55 | -0.06% |
| S&P/ASX 200 | 8,757.80 | 25.90 | 0.30% |
| SSE Composite Index | 3,952.13 | 2.22 | 0.06% |